Techniques for the detection of disease biomarkers are key components in the protection of human health. While work over the last few decades has redefined the low-level measurement of disease biomarkers, the translation of these capabilities from the formal clinical setting to point-of-need (PON) usage has been much more limited. This paper presents the results of experiments designed to examine the potential utility of a handheld Raman spectrometer as a PON electronic reader for a sandwich immunoassay based on surface-enhanced Raman scattering (SERS). In so doing, the study herein used a recently developed procedure for the SERS detection of phospho-myo-inositol-capped lipoarabinomannan (PILAM) as a means to compare the performance of laboratory-grade and handheld instrumentation and, therefore, gauge the utility of the handheld instrument for PON deployment. Phospho-myo-inositol-capped lipoarabinomannan is a non-pathogenic simulant for mannose-capped lipoarabinomannan (ManLAM), which is an antigenic marker found in serum and other body fluids of individuals infected with tuberculosis (TB). The results of the measurements with the field-portable spectrometer were then compared to those obtained for the same samples when using a much more sensitive benchtop Raman spectrometer. The results, albeit under different operational settings for the two spectrometers (e.g., signal integration time), are promising in that the limit of detection found for PILAM spiked in human serum when using the handheld system (0.18 ng/mL) approached that of the benchtop instrument (0.032 ng/mL). This work also: (1) identified potential adaptations (e.g., optimization of the plasmonically enhanced response for measurement by the handheld unit through a change in the excitation wavelength) to tighten the gap in performance; and (2) briefly examined the next steps and potential processes required to move this immunoassay platform closer to PON utility.
PaiN.P.VadnaisC.DenkingerC.EngelN.et al.“Point-of-Care Testing for Infectious Diseases: Diversity, Complexity, and Barriers in Low- and Middle-Income Countries”. PLoS Med. 2012. 9(9): e1001306.
2.
DumlaoM.SinuesP.M.-L.NudnovaM.ZenobiR.“Real-Time Detection of Chemical Warfare Agent Simulants in Forensic Samples Using Active Capillary Plasma Ionization with Benchtop and Field-Deployable Mass Spectrometers”. Anal. Methods. 2014. 6(11): 3604–3609.
3.
GałuszkaA.MigaszewskiZ.M.NamieśnikJ.“Moving Your Laboratories to the Field–Advantages and Limitations of the Use of Field Portable Instruments in Environmental Sample Analysis”. Environ. Res. 2015. 140: 593–603.
4.
GrimmeJ.KingT.JoK.D.CropekD.et al.“Development of Fieldable Lab-on-a-Chip Systems for Detection of a Broad Array of Targets from Toxicants to Biowarfare Agents”. J. Nanotechnol. Eng. Med. 2013. 4(2): 020904.
GrangerJ.H.SchlotterN.E.CrawfordA.C.PorterM.D.“Prospects for Point-of-Care Pathogen Diagnostics Using Surface-Enhanced Raman Scattering (SERS)”. Chem. Soc. Rev. 2016. 45(14): 3865–3882.
7.
McNerneyR.DaleyP.“Towards a Point-of-Care Test for Active Tuberculosis: Obstacles and Opportunities”. Nat. Rev. Microbiol. 2011. 9(3): 204–213.
8.
WangS.LifsonM.A.InciF.LiangL.-G.et al.“Advances in Addressing Technical Challenges of Point-of-Care Diagnostics in Resource-Limited Settings”. Expert Rev. Mol. Diagn. 2016. 16(4): 449–459.
9.
PaltielA.D.WalenskyR.P.“Home HIV Testing: Good News But Not a Game Changer”. Ann. Intern. Med. 2012. 157(10): 744–746.
10.
PaiN.P.BalramB.ShivkumarS.Martinez-CajasJ.L.et al.“Head-to-Head Comparison of Accuracy of a Rapid Point-of-Care HIV Test with Oral Versus Whole-Blood Specimens: A Systematic Review and Meta-Analysis”. Lancet Infect. Dis. 2012. 12(5): 373–380.
11.
ZhengJ.PangS.LabuzaT.P.HeL.“Semi-Quantification of Surface-Enhanced Raman Scattering Using a Handheld Raman Spectrometer: A Feasibility Study”. Analyst. 2013. 138(23): 7075–7078.
12.
PeelingR.W.HolmesK.K.MabeyD.RonaldA.“Rapid Tests for Sexually Transmitted Infections (STIs): The Way Forward”. Sex Transm. Infect. 2006. 82(Suppl 5): v1–v6.
13.
MabeyD.PeelingR.W.UstianowskiA.PerkinsM.D.“Tropical Infectious Diseases: Diagnostics for the Developing World”. Nat. Rev. Microbiol. 2004. 2(3): 231–240.
14.
GrangerJ.GrangerM.FirpoM.MulvihillS.et al.“Toward Development of a Surface-Enhanced Raman Scattering (SERS)-Based Cancer Diagnostic Immunoassay Panel”. Analyst. 2013. 138(2): 410–416.
15.
HossainA.CanningJ.AstS.RutledgeP.J.et al.“Lab-in-a-Phone: Smartphone-Based Portable Fluorometer for pH Measurements of Environmental Water”. IEEE Sens. J. 2015. 15(9): 5095–5102.
16.
ChoiJ.GaniA.W.BechsteinD.J.LeeJ.-R.et al.“Portable, One-Step, and Rapid GMR Biosensor Platform with Smartphone Interface”. Biosens. Bioelectron. 2016, pp. 851–857.
17.
WuG.ZamanM.H.“Low-Cost Tools for Diagnosing and Monitoring HIV Infection in Low-Resource Settings”. Bull. WHO. 2012. 90(12): 914–920.
18.
PaiM.MinionJ.SohnH.ZwerlingA.et al.“Novel and Improved Technologies for Tuberculosis Diagnosis: Progress and Challenges”. Clin. Chest Med. 2009. 30(4): 701–716.
19.
CrawfordA.C.LaurentiusL.B.MulvihillT.S.GrangerJ.H.et al.“Detection of the Tuberculosis Antigenic Marker Mannose-Capped Lipoarabinomannan in Pretreated Serum by Surface-Enhanced Raman Scattering”. Analyst. 2017. 142: 186–196.
LevyH.“A Reevaluation of Sputum Microscopy and Culture in the Diagnosis of Pulmonary Tuberculosis”. Chest. 1989. 95(6): 1193–1197.
22.
NorbisL.AlagnaR.TortoliE.CodecasaL.R.et al.“Challenges and Perspectives in the Diagnosis of Extrapulmonary Tuberculosis”. Expert Rev. Anti-Infect. Ther. 2014. 12(5): 633–647.
23.
PaiM.O’BrienR.“New Diagnostics for Latent and Active Tuberculosis: State of the Art and Future Prospects”. Semin. Respir. Crit. Care Med. 2008. 29(05): 560–568.
24.
StevensW.S.MarshallT.M.“Challenges in Implementing HIV Load Testing in South Africa”. J. Infect. Dis. 2010. 201(Supplement 1): S78–S84.
25.
Honore-BouaklineS.VincensiniJ.GiacuzzoV.LagrangeP.et al.“Rapid Diagnosis of Extrapulmonary Tuberculosis by PCR: Impact of Sample Preparation and DNA Extraction”. J. Clin. Microbiol. 2003. 41(6): 2323–2329.
26.
AbebeF.Holm-HansenC.WikerH.BjuneG.“Progress in Serodiagnosis of Mycobacterium tuberculosis Infection”. Scand. J. Immunol. 2007. 66(2–3): 176–191.
27.
ReitherK.SaathoffE.JungJ.MinjaL.T.et al.“Low Sensitivity of a Urine LAM-ELISA in the Diagnosis of Pulmonary Tuberculosis”. BMC Infect. Dis. 2009. 9(141): 1–10.
28.
TucciP.González-SapienzaG.MarinM.“Pathogen-Derived Biomarkers for Active Tuberculosis Diagnosis”. Front. Microbiol. 2014. 5(549): 1–6.
29.
PeterJ.GreenC.HoelscherM.MwabaP.et al.“Urine for the Diagnosis of Tuberculosis: Current Approaches, Clinical Applicability, and New Developments”. Curr. Opin. Pulm. Med. 2010. 16(3): 262–270.
30.
BoehmeC.MolokovaE.MinjaF.GeisS.et al.“Detection of Mycobacterial Lipoarabinomannan with an Antigen-Capture ELISA in Unprocessed Urine of Tanzanian Patients with Suspected Tuberculosis”. Trans. R. Soc. Trop. Med. Hyg. 2005. 99(12): 893–900.
31.
el-AttyH.E.-S.A.MohamadBakrR.El-HelbawyR.FathyabbassH.et al.“The Value of Serum Lipoarabinomannan in the Diagnosis of Pulmonary Tuberculosis”. Menoufia Med. J. 2014. 27(4): 733–739.
32.
LaurentiusL.B.CrawfordA.C.MulvihillT.S.GrangerJ.H.et al.“Importance of Specimen Pretreatment for the Low-Level Detection of Mycobacterial Lipoarabinomannan in Human Serum”. Analyst. 2017. 142(1): 177–185.
33.
ChatterjeeD.“Lipoarabinomannan. Multiglycosylated Form of the Mycobacterial Mannosylphosphatidylinositols”. J. Biol. Chem. 1992. 267(9): 6228–6233.
34.
DeP.AminA.G.ValliE.PerkinsM.D.et al.“Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine”. PLoS One. 2015. 10(12): e0144088.
35.
ChatterjeeD.LowellK.RivoireB.McNeilM.R.et al.“Lipoarabinomannan of Mycobacterium tuberculosis. Capping with Mannosyl Residues in Some Strains”. J. Biol. Chem. 1992. 267(9): 6234–6239.
36.
ChatterjeeD.BozicC.M.McNeilM.R.BrennanP.J.“Structural Features of the Arabinan Component of the Lipoarabinomannan of Mycobacterium Tuberculosis”. J. Biol. Chem. 1991. 266(15): 9652–9660.
37.
LudwiczakP.BrandoT.MonsarratB.PuzoG.“Structural Characterization of Mycobacterium Tuberculosis Lipoarabinomannans by the Combination of Capillary Electrophoresis and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry”. Anal. Chem. 2001. 73(10): 2323–2330.
38.
EtienneG.LavalF.VilleneuveC.DinadayalaP.et al.“The Cell Envelope Structure and Properties of Mycobacterium smegmatis mc2155: Is There a Clue for the Unique Transformability of the Strain?”. Microbiology. 2005. 151(6): 2075–2086.
39.
MishraA.K.DriessenN.N.AppelmelkB.J.BesraG.S.“Lipoarabinomannan and Related Glycoconjugates: Structure, Biogenesis and Role in Mycobacterium Tuberculosis Physiology and Host–Pathogen Interaction”. FEMS Microbiol. Rev. 2011. 35(6): 1126–1157.
40.
CaoB.WilliamsS.J.“Chemical Approaches for the Study of the Mycobacterial Glycolipids Phosphatidylinositol Mannosides, Lipomannan and Lipoarabinomannan”. Nat. Prod. Rep. 2010. 27(6): 919–947.
41.
ChatterjeeD.KhooK.H.“Mycobacterial Lipoarabinomannan: An Extraordinary Lipoheteroglycan with Profound Physiological Effects”. Glycobiology. 1998. 8(2): 113–120.
42.
PetzoldC.J.StantonL.H.LearyJ.A.“Structural Characterization of Lipoarabinomannans from Mycobacterium Tuberculosis and Mycobacterium Smegmatis by ESI Mass Spectrometry”. J. Am. Soc. Mass Spectrom. 2005. 16(7): 1109–1116.
43.
VenisseA.BerjeaudJ.M.ChaurandP.GilleronM.et al.“Structural Features of Lipoarabinomannan from Mycobacterium Bovis BCG. Determination of Molecular Mass by Laser Desorption Mass Spectrometry”. J. Biol. Chem. 1993. 268(17): 12401–12411.
44.
KhooK.H.DouglasE.AzadiP.InamineJ.M.et al.“Truncated Structural Variants of Lipoarabinomannan in Ethambutol Drug-Resistant Strains of Mycobacterium smegmatis: Inhibion of Arabinan Biosynthesis by Ethambutol”. J. Biol. Chem. 1996. 271(45): 28682–28690.
MauraR.B.FérnandezS.ReyesG.PerezJ.L.et al.“Evaluation of the Potential of Mycobacterium Smegmatis as Vaccine Candidate Against Tuberculosis by in Silico and in Vivo Studies”. VacciMonitor. 2010. 19(1): 20–26.
47.
ReyratJ.M.KahnD.“Mycobacterium Smegmatis: An Absurd Model for Tuberculosis?”. Trends Microbiol. 2001. 9(10): 472–474.
48.
MohanA.PadiadpuJ.BaloniP.ChandraN.“Complete Genome Sequences of a Mycobacterium smegmatis Laboratory Strain (MC2 155) and Isoniazid-Resistant (4XR1/R2) Mutant Strains”. GenomA. 2015. 3(1): 1–2.
49.
AkinolaR.O.MazanduG.K.MulderN.J.“A Systems Level Comparison of Mycobacterium tuberculosis, Mycobacterium leprae and Mycobacterium smegmatis Based on Functional Interaction Network Analysis”. J. Bacteriol. Parasitol. 2014. 4(1): 1–11.
50.
WaagmeesterA.ThompsonJ.ReyratJ.-M.“Identifying Sigma Factors in Mycobacterium smegmatis by Comparative Genomic Analysis”. Trends Microbiol. 2005. 13(11): 505–509.
51.
GrubishaD.S.LipertR.J.ParkH.-Y.DriskellJ.D.et al.“Femtomolar Detection of Prostate-Specific Antigen: An Immunoassay Based on Surface-Enhanced Raman Scattering and Immunogold Labels”. Anal. Chem. 2003. 75(21): 5936–5943.
52.
DriskellJ.D.KwartaK.M.LipertR.J.PorterM.D.et al.“Low-Level Detection of Viral Pathogens by a Surface-Enhanced Raman Scattering Based Immunoassay”. Anal. Chem. 2005. 77(19): 6147–6154.
53.
PorterM.D.LipertR.SiperkoL.WangG.et al.“SERS as a Bioassay Platform: Fundamentals, Design, and Applications”. Chem. Soc. Rev. 2008. 37(5): 1001–1011.
54.
DriskellJ.D.LipertR.J.PorterM.D.“Labeled Gold Nanoparticles Immobilized at Smooth Metallic Substrates: Systematic Investigation of Surface Plasmon Resonance and Surface-Enhanced Raman Scattering”. J. Phys. Chem. B. 2006. 110(35): 17444–17451.
55.
ParkH.-Y.DriskellJ.KwartaK.M.LipertR.J.et al.“Ultrasenstive Immunoassays Based on Surface-Enhanced Raman Scattering by Immunological Labels”. In: KneippK.MoskovitsM.KneipH. (eds). Surface-Enhanced Raman Scattering: Physics and Applications, Berlin: Springer, 2006, pp. 427–446.
56.
E.G. Roy, C. Dentinger, C. Robotham. “Detection of Homemade Explosives Using Raman Excitation at 1064 nm”. Proc. SPIE 9454, Detection and Sensing of Mines, Explosive Objects, and Obscured Targets. 2015. 94540U-U-5.
57.
SchmidtH.SowoidnichK.KronfeldtH.-D.“A Prototype Hand-Held Raman Sensor for the in Situ Characterization of Meat Quality”. Appl. Spectrosc. 2010. 64(8): 888–894.
58.
HanZ.LiuH.MengJ.YangL.et al.“Portable Kit for Identification and Detection of Drugs in Human Urine Using Surface-Enhanced Raman Spectroscopy”. Anal. Chem. 2015. 87(18): 9500–9506.
59.
MohsA.M.ManciniM.C.SinghalS.ProvenzaleJ.M.et al.“Hand-Held Spectroscopic Device for In Vivo and Intraoperative Tumor Detection: Contrast Enhancement, Detection Sensitivity, and Tissue Penetration”. Anal. Chem. 2010. 82(21): 9058–9065.
CarronK.CoxR.“Qualitative Analysis and the Answer Box: A Perspective on Portable Raman Spectroscopy”. Anal. Chem. 2010. 82(9): 3419–3425.
62.
MooreD.S.McGraneS.D.“Comparative Infrared and Raman Spectroscopy of Energetic Polymers”. J. Mol. Struct. 2003, pp. 661561–566.
63.
LewisI.R.DanielN.W.JrGriffithsP.R.“Interpretation of Raman Spectra of Nitro-Containing Explosive Materials. Part I: Group Frequency and Structural Class Membership”. Appl. Spectrosc. 1997. 51(12): 1854–1867.
64.
LalkhenA.G.McCluskeyA.“Clinical Tests: Sensitivity and Specificity”. Cont. Educ. Anaesth. Crit. Care Pain. 2008. 8(6): 221–223.
CrawfordA.C.Surface-Enhanced Raman Scattering for the Reliable and Reproducible Detection of Disease Antigens in Biologically Relevant Media. [Doctor of Philosophy in Chemistry Dissertation], Salt Lake City, UT: Utah The University of Utah, 2016.
68.
AverittR.D.WestcottS.L.HalasN.J.“Linear Optical Properties of Gold Nanoshells”. J. Opt. Soc. Am. B. 1999. 16(10): 1824–1832.
69.
JacksonJ.B.HalasN.J.“Surface-Enhanced Raman Scattering on Tunable Plasmonic Nanoparticle Substrates”. Proc. Natl. Acad. Sci. 2004. 101(52): 17930–17935.
McFarlandA.D.YoungM.A.DieringerJ.A.Van DuyneR.P.“Wavelength-Scanned Surface-Enhanced Raman Excitation Spectroscopy”. J. Phys. Chem. B. 2005. 109(22): 11279–11285.
74.
McCreeryR.L.“Instrumentation Overview and Spectrometer Performance”. In: WinefordnerJ.D. (ed). Raman Spectroscopy for Chemical Analysis, New York: Wiley-Interscience, 2005. Chap. 5, pp. 73–83.
75.
WangY.AlsmeyerD.C.McCreeryR.L.“Raman Spectroscopy of Carbon Materials: Structural Basis of Observed Spectra”. Chem. Mater. 1990. 2(5): 557–563.
76.
ChuP.K.LiL.“Characterization of Amorphous and Nanocrystalline Carbon Films”. Mater. Chem. Phys. 2006. 96(2): 253–277.
77.
HodkiewiczJ.“Characterizing Carbon Materials with Raman Spectroscopy”. Thermo Sci. App. Note. 2010, pp. 51946.
78.
SolopovaN.DubrovinskaiaN.DubrovinskyL.“Raman Spectroscopy of Glassy Carbon Up to 60 GPa”. Appl. Phys. Lett. 2013. 102(12): 121909.
79.
XueJ.ZhuQ.LiuJ.LiY.et al.“Gold Nanoarray Deposited Using Alternating Current for Emission Rate-Manipulating Nanoantenna”. Nanoscale Res. Lett. 2013. 8(295): 1–8.
80.
GrangerJ.H.SkuratovskyA.PorterM.D.ScaifeC.L.et al.“Coupling Solid-Phase Microextractions and Surface-Enhanced Raman Scattering: Towards a Point-of-Need Tool for Hepatic Cancer Screening”. Anal. Methods. 2017. 9(32): 4641–4646.
81.
GrahamD.GoodacreR.“Chemical and Bioanalytical Applications of Surface Enhanced Raman Scattering Spectroscopy”. Chem. Soc. Rev. 2008. 37(5): 883–884.
82.
DuyenH.T.NgocT.V.HaD.T.HangV.T.et al.“Kinetics of Plasma Viremia and Soluble Nonstructural Protein 1 Concentrations in Dengue: Differential Effects According to Serotype and Immune Status”. J. Infect. Dis. 2011. 203(9): 1292–1300.
83.
JimenezA.Rees-ChannerR.R.PereraR.GamboaD.et al.“Analytical Sensitivity of Current Best-in-Class Malaria Rapid Diagnostic Tests”. Malar. J. 2017. 16(128): 1–9.
84.
WorbsS.FiebigU.ZelenyR.SchimmelH.et al.“Qualitative and Quantitative Detection of Botulinum Neurotoxins from Complex Matrices: Results of the First International Proficiency Test”. Toxins. 2015. 7(12): 4935–4966.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
